skip navigation nih record
Vol. LXIV, No. 5
March 2, 2012
cover

previous story

next story



Duke’s Califf Addresses Clinical Trials, Mar. 8 in Bldg. 45

Dr. M. Roy Wilson

Dr. Robert M. Califf, vice chancellor for clinical research, director of Duke Translational Medicine Institute and professor of medicine at Duke University Medical Center, will speak on “Innovative Approaches to Clinical Trials,” on Thursday, Mar. 8, from 10 a.m. to noon in Bldg. 45, Rms. E1-E2.

With the science of clinical trials evolving quickly, Califf will discuss the role and value non-randomized controlled trials have in medical research and clinical trials. The number of therapeutic interventions is growing and the need for clear scientific evidence that these interventions work is mounting. Recent emphasis on evidence-based medicine, patient-centered outcomes research, learning and accountable health care systems underscores the fact that most clinical trials fail to provide the evidence needed to inform medical decision-making. The need for a balance between commercial interests and public health is warranted.

In addition to his faculty appointments at Duke, Califf is editor-in-chief of American Heart Journal and is the author or coauthor of more than 1,000 peer-reviewed articles. He also serves as a contributing editor for www.theheart.org, an online information resource for health care professionals involved in the diagnosis and management of cardiovascular disease.

Califf received his undergraduate degree from Duke and his M.D. from Duke University Medical School.

The seminar is sponsored by the Office of Disease Prevention and several institutes. Registration is not required; seating is on a first-come, first-served basis. Sign language interpreters will be provided. For reasonable accommodation, contact Paris Watson at Paris.Watson@nih.gov, (301) 496-6615. NIHRecord Icon


back to top of page